Catalyst Wire Dossier Catalyst Wire Dossier

Kromeya

adalimumab · Fresenius Kabi Deutschland GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kromeya, covering 2020-03-25 to 2020-03-25. Get the full timeline:

Most recent: EMA Withdrawn: Kromeya (adalimumab) — Fresenius Kabi Deutschland GmbH

See pricing